← Leaderboards
Vincent Sandanayaka
Nirogyone Therapeutics, Llc
$2,792,210
Attributed
$2,792,210
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2017–21$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,792,210 · 3
By mechanism
R44$2,000,000 · 1
R43$792,210 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Xenograft Model”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$15,940,517
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$6,727,999
- Paul Northcott · St. Jude Children'S Research Hospital$6,159,036
Research focus
Xenograft ModelDoseMouse ModelTumor MicroenvironmentMalignant Breast NeoplasmRegimenLactate TransporterMda Mb 231In VivoTumorInhibitor/AntagonistGlycolysisCancer CellSmall MoleculeExperimental StudyCell MembraneBaseMalignant NeoplasmsCellsCessation Of LifeChemotherapyInsightBreast Cancer DiagnosisEffective Therapy
Grant awards (6)
Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer$854,530
R44 · FY2021 · CA · contact PI
Development of Tumor and Immuno-Metabolism Based Small Molecule Therapeutics for Refractory Breast Cancer$1,145,470
R44 · FY2020 · CA · contact PI
TUMOR AND IMMUNO-METABOLISM BASED LACTATE TRANSPORTER INHIBITORs FOR METASTATIC MELANOMA$292,210
R43 · FY2019 · CA · contact PI
INHIBITORS OF CELLULAR TRANSPORTERS FOR THE TREATMENT OF TNBC$150,000
R43 · FY2018 · CA · contact PI
INHIBITORS OF CELLULAR TRANSPORTERS FOR THE TREATMENT OF TNBC$50,000
R43 · FY2018 · CA · contact PI
INHIBITORS OF CELLULAR TRANSPORTERS FOR THE TREATMENT OF TNBC$300,000
R43 · FY2017 · CA · contact PI